CLINICAL_TRIALS
trial_result
· 2017-10-05
Clinical Trial Update: Post-Marketing Surveillance Study To Observe INLYTA® Treatment Dosing Pattern, Safety And Effectiveness In Taiwan Real World Routine Practice
Summary
This post-marketing surveillance study evaluates dosing patterns, safety, and effectiveness of INLYTA (axitinib) in real-world Taiwan practice.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Renal Cell Carcinoma | Status: COMPLETED | Results posted: 2017-10-05